A recent Center for Mental Health briefing documents the evidence on the mental health of older people in England and what kind of support they receive.
Novartis reportedly in talks to buy MorphoSys; Astellas cuts PhII program; Silence’s $120M private placement
Plus, news about Adverum, BridgeBio Pharma, Vaxcyte, Corbus and Immunocore: Novartis reportedly in deal talks with MorphoSys: The Swiss Big Pharma is in advanced talks